Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-11-01 Sale |
2023-11-03 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
1,092 | $10.42 | $11,379 | 0 (Direct) |
View |
2023-09-06 Sale |
2023-09-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,961 | $15.06 | $59,637 | 341,320 (Direct) |
View |
2023-08-07 Sale |
2023-08-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $15.52 | $159,580 | 195,025 (Direct) |
View |
2023-07-28 Sale |
2023-08-01 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
5,478 | $18 | $98,604 | 383,381 (Direct) |
View |
2023-07-17 Sale |
2023-07-19 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
4,522 | $18.11 | $81,896 | 388,859 (Direct) |
View |
2023-07-06 Sale |
2023-07-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $16.66 | $171,284 | 205,308 (Direct) |
View |
2023-07-05 Sale |
2023-07-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $17.3 | $38,915 | 139,139 (Direct) |
View |
2023-07-03 Sale |
2023-07-05 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $18 | $180,000 | 393,381 (Direct) |
View |
2023-06-06 Sale |
2023-06-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $16.28 | $167,416 | 215,591 (Direct) |
View |
2023-06-05 Sale |
2023-06-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $16.26 | $36,576 | 141,389 (Direct) |
View |
2023-05-19 Sale |
2023-05-23 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
65 | $19.5 | $1,268 | 22,204 (Direct) |
View |
2023-05-17 Sale |
2023-05-19 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
1,090 | $19.59 | $21,356 | 22,269 (Direct) |
View |
2023-05-05 Sale |
2023-05-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $20.87 | $46,957 | 143,639 (Direct) |
View |
2023-05-08 Sale |
2023-05-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $21.8 | $224,160 | 225,874 (Direct) |
View |
2023-05-03 Sale |
2023-05-05 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus SENIOR VICE PRESIDENT, CMC |
759 | $20.79 | $15,779 | 0 (Direct) |
View |
2023-05-01 Sale |
2023-05-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,693 | $20.63 | $323,745 | 403,381 (Direct) |
View |
2023-04-21 Sale |
2023-04-25 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $19.5 | $78,000 | 22,068 (Direct) |
View |
2023-04-06 Sale |
2023-04-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $18.17 | $186,829 | 234,867 (Direct) |
View |
2023-04-05 Sale |
2023-04-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $18.2 | $40,942 | 145,889 (Direct) |
View |
2023-04-03 Sale |
2023-04-05 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $19.39 | $290,916 | 418,381 (Direct) |
View |
2023-03-06 Sale |
2023-03-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,282 | $23.73 | $243,954 | 245,150 (Direct) |
View |
2023-03-06 Sale |
2023-03-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $23.75 | $53,440 | 148,139 (Direct) |
View |
2023-03-01 Sale |
2023-03-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $23.81 | $357,196 | 433,381 (Direct) |
View |
2023-02-06 Sale |
2023-02-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $24.59 | $252,881 | 317,432 (Direct) |
View |
2023-02-06 Sale |
2023-02-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $24.27 | $54,612 | 212,389 (Direct) |
View |
2023-02-01 Sale |
2023-02-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $22.68 | $340,197 | 448,381 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-09-06 Exercise |
2023-09-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
1,548 | $2.14 | 341,320 (Direct) |
View |
2023-09-06 Exercise |
2023-09-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 341,320 (Direct) |
View |
2023-09-06 Exercise |
2023-09-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,961 | $0 | 341,320 (Direct) |
View |
2023-08-07 Exercise |
2023-08-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 195,025 (Direct) |
View |
2023-08-07 Exercise |
2023-08-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 195,025 (Direct) |
View |
2023-08-07 Exercise |
2023-08-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 195,025 (Direct) |
View |
2023-07-28 Exercise |
2023-08-01 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
5,478 | $2.14 | 383,381 (Direct) |
View |
2023-07-28 Exercise |
2023-08-01 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
5,478 | $0 | 383,381 (Direct) |
View |
2023-07-17 Exercise |
2023-07-19 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
4,522 | $2.14 | 388,859 (Direct) |
View |
2023-07-17 Exercise |
2023-07-19 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
4,522 | $0 | 388,859 (Direct) |
View |
2023-07-10 Option Award |
2023-07-11 5:06 pm |
N/A 2033-07-09 |
Aerovate Therapeutics Inc. | AVTE | Dable Habib J Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-07-06 Exercise |
2023-07-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 205,308 (Direct) |
View |
2023-07-06 Exercise |
2023-07-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 205,308 (Direct) |
View |
2023-07-06 Exercise |
2023-07-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 205,308 (Direct) |
View |
2023-07-05 Exercise |
2023-07-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 139,139 (Direct) |
View |
2023-07-05 Exercise |
2023-07-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 139,139 (Direct) |
View |
2023-07-05 Exercise |
2023-07-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 139,139 (Direct) |
View |
2023-07-03 Exercise |
2023-07-05 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $2.14 | 393,381 (Direct) |
View |
2023-07-03 Exercise |
2023-07-05 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $0 | 393,381 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
2023-06-06 Exercise |
2023-06-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 215,591 (Direct) |
View |
2023-06-06 Exercise |
2023-06-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 215,591 (Direct) |
View |
2023-06-06 Exercise |
2023-06-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 215,591 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Resnick Joshua Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-05 Exercise |
2023-06-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 141,389 (Direct) |
View |
2023-06-05 Exercise |
2023-06-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 141,389 (Direct) |
View |
2023-06-05 Exercise |
2023-06-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 141,389 (Direct) |
View |
2023-05-19 Exercise |
2023-05-23 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
65 | $1.74 | 22,204 (Direct) |
View |
2023-05-19 Exercise |
2023-05-23 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
65 | $0 | 22,204 (Direct) |
View |
2023-05-17 Exercise |
2023-05-19 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
1,090 | $1.74 | 22,269 (Direct) |
View |
2023-05-17 Exercise |
2023-05-19 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
1,090 | $0 | 22,269 (Direct) |
View |
2023-05-05 Exercise |
2023-05-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 143,639 (Direct) |
View |
2023-05-05 Exercise |
2023-05-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 143,639 (Direct) |
View |
2023-05-05 Exercise |
2023-05-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 143,639 (Direct) |
View |
2023-05-08 Exercise |
2023-05-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 225,874 (Direct) |
View |
2023-05-08 Exercise |
2023-05-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 225,874 (Direct) |
View |
2023-05-08 Exercise |
2023-05-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $0 | 225,874 (Direct) |
View |
2023-05-01 Exercise |
2023-05-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 403,381 (Direct) |
View |
2023-05-01 Exercise |
2023-05-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 403,381 (Direct) |
View |
2023-04-21 Exercise |
2023-04-25 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $1.74 | 22,068 (Direct) |
View |
2023-04-21 Exercise |
2023-04-25 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $0 | 22,068 (Direct) |
View |
2023-04-06 Exercise |
2023-04-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 234,867 (Direct) |
View |
2023-04-06 Exercise |
2023-04-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 234,867 (Direct) |
View |
2023-04-06 Exercise |
2023-04-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 234,867 (Direct) |
View |
2023-04-05 Exercise |
2023-04-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 145,889 (Direct) |
View |
2023-04-05 Exercise |
2023-04-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 145,889 (Direct) |
View |
2023-04-05 Exercise |
2023-04-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 145,889 (Direct) |
View |
2023-04-03 Exercise |
2023-04-05 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 418,381 (Direct) |
View |
2023-04-03 Exercise |
2023-04-05 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 418,381 (Direct) |
View |
Ownership |
2023-03-08 6:01 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Pigot Timothy Chief Commercial Officer |
0 | $0 | 182,960 (Direct) |
View |
2023-03-07 Option Award |
2023-03-08 6:00 pm |
N/A 2033-03-06 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
139,067 | $0 | 139,067 (Direct) |
View |
2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,870 | $2.14 | 245,150 (Direct) |
View |
2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 245,150 (Direct) |
View |
2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,282 | $0 | 245,150 (Direct) |
View |
2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 148,139 (Direct) |
View |
2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 148,139 (Direct) |
View |
2023-03-06 Exercise |
2023-03-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 148,139 (Direct) |
View |
2023-03-01 Exercise |
2023-03-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 433,381 (Direct) |
View |
2023-03-01 Exercise |
2023-03-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 433,381 (Direct) |
View |
2023-02-07 Option Award |
2023-02-08 6:10 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus SENIOR VICE PRESIDENT, CMC |
62,000 | $0 | 62,000 (Direct) |
View |
2023-02-07 Option Award |
2023-02-08 6:10 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
85,000 | $0 | 85,000 (Direct) |
View |
2023-02-07 Option Award |
2023-02-08 6:10 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
62,000 | $0 | 63,960 (Direct) |
View |
2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,872 | $2.14 | 317,432 (Direct) |
View |
2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 317,432 (Direct) |
View |
2023-02-07 Option Award |
2023-02-08 6:00 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
62,000 | $0 | 317,432 (Direct) |
View |
2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $0 | 317,432 (Direct) |
View |
2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 212,389 (Direct) |
View |
2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 212,389 (Direct) |
View |
2023-02-07 Option Award |
2023-02-08 6:00 pm |
N/A 2033-02-06 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
62,000 | $0 | 212,389 (Direct) |
View |
2023-02-06 Exercise |
2023-02-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 212,389 (Direct) |
View |
2023-02-01 Exercise |
2023-02-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 448,381 (Direct) |
View |
2023-02-01 Exercise |
2023-02-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 448,381 (Direct) |
View |